Completed PHASE3 INTERVENTIONAL 3-arm NCT00485940

Efficacy and Safety Study of Prucalopride for the Treatment of Patients With Chronic Constipation

A Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of R108512 Tablets in Subjects With Chronic Constipation

Sponsor: Movetis

Conditions Constipation

Interventions Placebo Prucalopride

Updated 6 times since 2017 Last updated: Sep 24, 2013 Started: Mar 31, 1998 Primary completion: May 31, 1999 Completion: May 31, 1999

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Constipation and is currently completed. Movetis leads this study, which shows 6 recorded versions since 1998 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Feb 2017 — Jun 2018 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Mar 1998

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Movetis

Data source: Movetis

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.